Compare Recursion Pharmaceuticals Inc (RXRX) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Recursion Pharmaceuticals Inc trades at $4.27 (market cap $2.14B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.4 (market cap $24.42B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 11.4× Recursion Pharmaceuticals Inc's market cap, and Direxion Daily Semiconductor Bull 3X Shares is more actively traded (100,232,380 versus 30,789,535). Which is the better fit depends on your goals — on Pluang, investors hold Recursion Pharmaceuticals Inc for 22 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| RXRX | SOXL | |
|---|---|---|
Market Cap | $2.14B | $24.42B |
Volume | 30,789,535 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $6.79 | $300.77 |
52-Week Low | $2.84 | $30.81 |
Typical Hold Time | 22 Days | 15 Days |
Enterprise Value | $1.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $4.05, down 5.15% today, with a bullish technical signal from moving averages. The company reported revenue of $74.26M in 2025 but a net loss of $644.76M, with negative profit margins. Recent news highlights strategic AI partnerships, including an extended data license with Tempus AI, aiming to fuel long-term growth despite current financial challenges.
The outlook remains speculative; the stock offers exposure to AI-driven drug discovery through a growing pipeline and partnerships, but high cash burn and lack of profitability pose significant risks. Analyst consensus is mixed with 40% buy ratings, reflecting optimism for future catalysts tempered by near-term financial weakness.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, trades at $141.3, down 11.08% with a bearish technical signal despite bullish moving averages. The semiconductor sector shows volatility with mixed news flow, ranging from strong AI demand to regulatory and tariff concerns. Recent price action reflects the leveraged ETF's sensitivity to chip stock movements, with support at $134 and resistance at $145.
Outlook remains cautious due to high leverage amplifying sector swings. Opportunities exist if semiconductor fundamentals strengthen, but risks include overcrowded trades and macroeconomic headwinds. Investors should weigh the ETF's structure against direct semiconductor exposure for risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
